Skip to content

A Study to Evaluate ARV-393 in Adult Participants with Advanced Non-Hodgkin’s Lymphoma

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-510136-36-00
Acronym
ARV-393-101
Enrollment
59
Registered
2024-09-10
Start date
2024-09-27
Completion date
Unknown
Last updated
2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Non-Hodgkin’s Lymphoma

Interventions

None listed

Sponsors

Arvinas Operations Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Denmark, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026